Month: March 2022

InvestmentPitch Media Video Discusses Dynacor Gold Mines’ February Gold Sales of US$16.7 Million, or Approximately CDN$21.2 Million, a 40.3% Increase over February 2021

Written by Customer Service on March 17, 2022. Posted in Dividend Reports And Estimates.

VANCOUVER, British Columbia, March 17, 2022 (GLOBE NEWSWIRE) — Montreal-based Dynacor Gold Mines (TSX:DNG), a dividend-paying industrial gold ore processor, has reported its monthly gold sales for February. The company reported February gold sales of US$16.7 million (unaudited), or approximately CDN$21.2 million, a 40.3% increase over February 2021. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Dynacor” in the search box. Dynacor also saw a 13.6% month-over-month increase from January....

CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer

Written by Customer Service on March 17, 2022. Posted in Public Companies.

In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical targets for the potential development of new therapies for rare diseases New research phase aims to substantiate earlier results and further leverage CENTOGENE’s Bio/Databank to evaluate rare genetic causes of neurodegenerative diseasesROSTOCK, Germany and BERLIN, March 17, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced an expansion of the Company’s data access and collaboration agreement with Pfizer Inc. The initial agreement, which granted Pfizer access to data of interest from CENTOGENE’s Bio/Databank, was established in 2019 to advance...

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Korea

Written by Customer Service on March 17, 2022. Posted in Public Companies.

LA JOLLA, Calif., March 17, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the Korean Intellectual Property Office which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of advanced nonalcoholic steatohepatitis (NASH). Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than May 2035. The allowed claims cover MN-001 (tipelukast) and MN-002 for the treatment of a patient with advanced NASH wherein the treatment is for reducing hepatic fibrosis in a patient suffering from advanced NASH. The allowed claims also cover advanced NASH patients...

WIRELESS TELECOM GROUP ANNOUNCES FOURTH QUARTER AND YEAR-END 2021 FINANCIAL RESULTS

Written by Customer Service on March 17, 2022. Posted in Public Companies.

Highlights for the year ended December 31, 2021:● Net revenues of $49.2 million, an increase of 18.0% compared to the same period last year● Gross Profit of $25.1 million, or 50.9% of net revenue, an increase of $4.1 million or 19.6% compared to the same period last year● Net income of $1.5 million, compared to a net loss of $8.1 million for the same period last year● Non-GAAP Adjusted EBITDA of $3.7 million, compared to Non-GAAP Adjusted EBITDA of $1.8 million for the same period last year● Cash provided by operations of $4.6 million, compared to $3.0 million for the same period last year● Excluding Microlab, backlog at December 31, 2021, was $9.2 million, a $2.1 million, or 30.4% year-over-year increaseHighlights for the quarter ended December 31, 2021:● Signed an agreement for the sale of Microlab to RF Industries...

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Top-line data from pivotal 4WHIM Phase 3 clinical trial in WHIM syndrome expected in 4Q22 Clinical and regulatory updates from ongoing chronic neutropenia Phase 1b trial anticipated during 2Q/3Q 2022 Additional Waldenström’s macroglobulinemia Phase 1b data expected in second half of 2022; supportive pre-clinical data to be presented at AACR 2022 Conference call today at 8:30 a.m. EDT BOSTON, March 17, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit people with diseases of the immune system, today reported financial results for the fourth quarter and twelve months ended December 31, 2021, and provided a corporate update. “We are very pleased with our many accomplishments in 2021, particularly completing enrollment...

Pharmacy Benefit Management Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

Pharmacy Benefit Management Market Covered By Key Companies – CVS Health, Express Scripts, OptumRx, Inc., Anthem, Inc., Centene Corporation, CIGNA, MedImpact. Pune, India, March 17, 2022 (GLOBE NEWSWIRE) — The global pharmacy benefit management market size is expected to grow speedily owing to the increasing demand for prescription drugs across the world, finds Fortune Business Insights™ in its report, titled “Pharmacy Benefit Management Market, 2022-2028”. In recent years, there has been an increasing need for life-saving drugs from the pharmaceutical industry, which has resulted in the rising demand for pharmacy benefit management across several regions. The pharmacy benefit management helps to provide on time and appropriate access to the critical medications to the patients around the world. The increasing demand for...

Behavioural Therapy Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

List of key players in Behavioural Therapy Market Report are – Magellan Health, Inc., Acadia Healthcare, Universal Health Services, Inc., Springstone, American Addiction Centers, Haven Behavioural Healthcare, Inc., Behavioural Health Group, PEOPLE’S CARE HOLDINGS, INC. Pune, India, March 17, 2022 (GLOBE NEWSWIRE) — The global behavioural therapy market size is projected to experience dynamic expansion in the forthcoming years owing to the increasing prevalence of behavioural disorders around the world, finds Fortune Business Insights™ in its report, titled Behavioural Therapy Market, 2021-2028. Over the years, there has been an increasing prevalence of behavioural disorders such as anxiety, depression, and others among the majority of the people across the world owing to the rising workload, poor mental condition, and other...

Alzheimer Drugs Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Alzheimer Drugs Market Research Report Are Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company., Merck Sharp & Dohme Corp., AstraZeneca, Biogen, AbbVie Inc., ALLERGAN, other players Pune, India, March 17, 2022 (GLOBE NEWSWIRE) — Increasing prevalence of Alzheimer’s disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer Drugs Market, says Fortune Business Insights in a report, titled Alzheimer Drugs Market Size, Share and Global Trend By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Antagonist, Combination Drugs, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2026. The healthcare industry is of the biggest industry in the world comprising...

Årsrapport 2021 for Investeringsforeningen PFA Invest

Written by Customer Service on March 17, 2022. Posted in Public Companies.

Hermed offentliggøres årsrapport 2021 for Investeringsforeningen PFA Invest, som bestyrelsen har godkendt dags dato. Årsrapporten vil umiddelbart efter offentliggørelsen være tilgængelig på Investeringsforeningen PFA Invests hjemmeside: www.pfainvest.dk Med venlig hilsenPFA Asset Management A/SAttachmentÅrsrapport_2021_PFA Invest

Eimskip: Annual Report 2021

Written by Customer Service on March 17, 2022. Posted in Public Companies.

Eimskip has published its Annual and Sustainability Report for the year 2021. The report is accessible here https://www.eimskip.is/2021/annual-report-2021/

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals